| Message: | Dexamethasone;Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11.beta.,16.alpha.)-
Molecular formula : C22H29FO5
MW : 392.46
CAS No. 50-54-02-2
nature : no
Preparation : No
purposes : for the main anti-inflammatory and anti-allergic, in rheumatoid arthritis and other diseases, such as collagen.
Pharmacokinetics:
indications: apply to the cataract extraction and intraocular lens implantation - induced postoperative ocular inflammation.
usage and consumption: in ophthalmic surgery and the end of viscoelastic material removed, with Precision Gear forceps removed from the packaging of the goods into an immediate or after the Housing Authority. If on the anterior chamber, iris should be placed on drug tablets basement 12:00 position; If on the post should be placed on artificial iris and lens surface before the 6:00 position, then conventional incision closed.
before use and the materials used to be in a sterile condition, unless immediate using this or any other time should not be open foil packaging.
adverse reaction: in clinical trials and found no implantation of the goods directly related systemic adverse reactions and local stimulus. Commodities generally will not cause the elevation of intraocular pressure; Because of individual differences, there will be dual elevation of intraocular pressure, but are reversible, can be returned to normal after treatment.
o
specifications: 0.06mg.
Storage: shading confined preservation.
Validity: tentative year and a half.
prescription drugs:
Warning:The information is only as a reference for new drug researcher and the patients or doctors can't use it as prescription basis! |
my account
